How To Lose A Study In 30 Days

Share Button


Ever wanted to lose a clinical trial? How about lose one in just under a month? Well folks, I’m here to tell you that it is possible, and actually happens more often than you might think. Usually Sponsors may terminate clinical research sites due to their lack of enrollment numbers, but there are also plenty of other sure-fire ways to get your Site booted! Check this video and please do NOT do anything that I mention!

Share Button

The Difference Between Crossover and Parallel Clinical Trials

Share Button


Thanks to the good folks over at Eli Lilly COI for creating an awesome infographic that explains the differences between crossover studies and parallel trials. Instead of writing about it here, check out the video and see the graphic below!
crossoverposter-r1-4

Share Button

When Clinical Research Coordinators Forget To Hustle!

Share Button


This video explains why an in-office pre-screening works much better at study enrollment than just emailing an Informed Consent Form to a potential study participant. It may seem obvious but still not done as much as it needs to be!

Share Button

How To Keep Your Clinical Trial Participant “No Shows” Down!

Share Button


Imagine that you just got hired as the lead recruiter for a clinical research clinic. On your first week, you managed to get 8 new screenings scheduled for the following week only to find out that 4 of them never showed up! Well as they say, “life is tough”, but there are some relatively simple solutions out there that may actually keep your “no show” rates down by a significant percentage. In this video, I answer a viewer’s questions in regards to a similar situation as the one explained above. Let me know if you have any strategies for keeping your clinical trial no shows to a minimum.
quotescover-JPG-47

Share Button

How To Tell Difference Between A CRO vs SMO In Clinical Research!

Share Button


In this week’s full length podcast, I dive into the viewer question box and pull out some interesting topics. The first is how CRO’s and Sponsors ensure that PI’s are truly reading the Serious Adverse Event Reports that they send to all research sites, or whether they are just signing and filing. The next question is how to tell the difference between a CRO and an SMO in clinical research. Another topic is PI availability versus the Sponsor’s ever increasing demands for more PI oversight and what we can expect in 2014 and 2015 in this industry. There are other topics I cover here as well and I hope you find some value out of it. quotescover-JPG-53

Share Button

Are There Any Regulations That Would Prevent Clinical Research Participants From Joining A Whole Bunch Of Studies?

Share Button


Self-explanatory topic that is also somewhat related to this video as they both are themed around the less-talked about issues in clinical research.

Share Button